drugset / Trial / NCT01090050
Treximet in the Treatment of Chronic Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being conducted to evaluate the hypothesis that use of Treximet in patients with chronic migraine, when used on a short term daily basis and as rescue for break through attacks, will reduce migraine frequency and impact.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | Oral |
| Comparator | Sumatriptan | Unknown | 85 mg | Oral |